Summary:
- The article discusses the appointment of Ramin Valian as the new CEO of Emmecell, a company focused on developing cell therapy platforms.
- Valian previously held a senior executive position at AbbVie, a major pharmaceutical company, bringing extensive experience in the biopharmaceutical industry to his new role.
- Emmecell is working on advancing its cell therapy technology, which could potentially be used to treat various diseases, and Valian's leadership is expected to help the company progress its research and development efforts.